Archives
-
EDC.HCl: Practical Coupling Workflow
2026-09-10
EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis and bioconjugation. It is intended for controlled in vitro chemical workflows; the supplied dossier provides no in vivo or clinical data and does not define a universally validated protocol for a specific substrate pair.
-
SOD Activity Assay: Practical Lab Guide
2026-09-10
This scenario-based guide explains how to distinguish SOD enzyme activity from broader oxidative stress and hydrogen peroxide measurements. It shows how Superoxide Dismutase (SOD) Activity Assay Kit, SKU K2035, can support controlled, practical workflows for cell and biological-fluid studies.
-
XAV-939: From Wnt Mechanism to Translational Strategy
2026-09-09
XAV-939, also known as NVP-XAV939, is more than a tankyrase inhibitor: it is a practical causal probe for testing how axin stabilization and Wnt/β-catenin suppression reshape cancer, fibrosis, bone, and regenerative biology.
-
Sodium Ascorbate for Reliable ROS Assays
2026-09-09
Learn how Sodium Ascorbate (SKU B1834) can support controlled ROS, viability, proliferation, and motility experiments in tumor-cell models. This scenario-based guide covers formulation, assay compatibility, protocol optimization, interpretation, and practical vendor selection without overstating translational evidence.
-
HyperScript RT SuperMix for qPCR Workflow Guide
2026-09-08
Build more reproducible two-step qRT-PCR workflows for difficult, low-abundance, or structurally complex RNA. This guide translates a p16-targeted antibody fragment-drug conjugate study into practical cDNA synthesis, assay design, normalization, and troubleshooting decisions.
-
GI 254023X: ADAM10 Inhibitor Workflows
2026-09-08
GI 254023X enables selective interrogation of ADAM10 sheddase activity across Jurkat signaling and endothelial barrier models. This guide translates product specifications and a synaptic assay framework into practical dosing, readout, and troubleshooting strategies for preclinical research.
-
GDC-0068 (RG7440): Spatial AKT–mTOR Logic
2026-09-07
GDC-0068 (RG7440) offers a powerful pan-AKT perturbation for studying how PI3K/Akt signaling shapes mTORC1-dependent growth, survival, and transcription. This thought-leadership article connects its genotype-aware use in oncology models with recent evidence that mTORC1 functions differently across cellular compartments, while clarifying why global Akt inhibition should be paired with spatially targeted tools rather than interpreted as a compartment-specific probe.
-
AI-Derived Prognostic Signature in HCC
2026-09-07
A multi-center study developed a consensus artificial intelligence-derived prognostic signature (CAIPS) for hepatocellular carcinoma by integrating machine-learning strategies across six cohorts. The seven-gene model linked risk scores with metabolic dysregulation, genomic instability, treatment-response patterns, candidate drugs, and PITX1-mediated tumor biology, providing a framework for biomarker-guided research rather than a substitute for prospective clinical validation.
-
Prednisolone in Glucocorticoid Signaling Research
2026-09-05
Use Prednisolone to build controlled glucocorticoid, inflammation, and immunology assays while separating receptor-driven effects from emerging ERAD-based degradation strategies. This workflow combines practical stock preparation, dose-response design, and controls that clarify what Prednisolone can—and cannot—demonstrate in membrane-protein studies.
-
Calpeptin Beyond Calpain: EVs and Fibrosis
2026-09-04
Calpeptin is a potent calpain inhibitor that links protease biology with pulmonary fibrosis research and extracellular-vesicle assays. This article develops an evidence-based framework for distinguishing direct calpain engagement, fibrosis and inflammation modulation, and residual EV-mediated phenotypes.
-
Calpeptin Workflows for Pulmonary Fibrosis
2026-09-04
Calpeptin gives researchers a practical way to interrogate calpain-dependent signaling alongside inflammatory, fibrotic, and cell-death readouts. This workflow emphasizes dose optimization, orthogonal validation, and troubleshooting for pulmonary fibrosis research rather than relying on a single viability endpoint.
-
High-Throughput BBB Permeability Modeling
2026-09-03
Hu and colleagues developed a Transwell surrogate blood-brain barrier model combining LLC-PK1-MOCK and LLC-PK1-MDR1 cells with a lysosomal-trapping correction strategy. Across 41 compounds, the platform linked MDR1-derived permeability with unbound brain distribution and improved interpretation of compounds showing low recovery from intracellular sequestration.
-
BH3 Mimetics Clear Senescent Breast Cancer Cells
2026-09-03
The 2020 Cell Death & Differentiation study shows that chemotherapy-induced senescent cells in TP53-wild-type breast cancer can remain biologically dangerous and selectively vulnerable to BH3 mimetics. Its sequential treatment strategy links senescent-cell survival dependencies, including BCL-XL and MCL1, to improved tumor regression and survival in a mouse model.
-
TaqI Restriction Endonuclease Protocol
2026-09-02
TaqI Restriction Endonuclease provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the 5′…T↓CGA…3′ site. It is intended for scientific research workflows such as DNA analysis and cloning, not for diagnostic or medical use.
-
HotStart 2X Green qPCR Master Mix for Liver qPCR
2026-09-02
Translate hepatic ketogenesis research into a practical SYBR Green workflow for measuring HMGCS2, ACSL1, and lipid-homeostasis transcripts. This guide combines hot-start specificity, assay controls, RNA-seq validation, and troubleshooting for reproducible liver gene expression studies.